|
1
|
Mantovani A, Bottazzi B, Colotta F,
Sozzani S and Ruco L: The origin and function of tumor-associated
macrophages. Immunol Today. 13:265–270. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hildenbrand R and Schaaf A: The
urokinase-system in tumor tissue stroma of the breast and breast
cancer cell invasion. Int J Oncol. 34:15–23. 2009.PubMed/NCBI
|
|
3
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gentleman RC, Carey VJ, Bates DM, et al:
Bioconductor: open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Purohit V, Rapaka R, Kwon OS and Song BJ:
Roles of alcohol and tobacco exposure in the development of
hepatocellular carcinoma. Life Sci. 92:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heuff G, Oldenburg HS, Boutkan H, et al:
Enhanced tumor growth in the rat liver after selective elimination
of Kupffer cells. Cancer Immunol Immunother. 37:125–130. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen JJ, Lin YC, Yao PL, et al:
Tumor-associated macrophages: the double-edged sword in cancer
progression. J Clin Oncol. 23:953–964. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goetze K, Walenta S, Ksiazkiewicz M,
Kunz-Schughart LA and Mueller-Klieser W: Lactate enhances motility
of tumor cells and inhibits monocyte migration and cytokine
release. Int J Oncol. 39:453–463. 2011.PubMed/NCBI
|
|
9
|
De Palma M and Lewis CE: Macrophage
regulation of tumor responses to anticancer therapies. Cancer Cell.
23:277–286. 2013.PubMed/NCBI
|
|
10
|
Horton LW, Yu Y, Zaja-Milatovic S,
Strieter RM and Richmond A: Opposing roles of murine duffy antigen
receptor for chemokine and murine CXC chemokine receptor-2
receptors in murine melanoma tumor growth. Cancer Res.
67:9791–9799. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smith HA and Kang Y: The
metastasis-promoting roles of tumor-associated immune cells. J Mol
Med. 91:411–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sawant A, Hensel JA, Chanda D, et al:
Depletion of plasmacytoid dendritic cells inhibits tumor growth and
prevents bone metastasis of breast cancer cells. J Immunol.
189:4258–4265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White ES, Strom SR, Wys NL and Arenberg
DA: Non-small cell lung cancer cells induce monocytes to increase
expression of angiogenic activity. J Immunol. 166:7549–7555. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin EY, Li JF, Gnatovskiy L, et al:
Macrophages regulate the angiogenic switch in a mouse model of
breast cancer. Cancer Res. 66:11238–11246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagemann T, Robinson SC, Schulz M, et al:
Enhanced invasiveness of breast cancer cell lines upon
co-cultivation with macrophages is due to TNF-α dependent
up-regulation of matrix metalloproteases. Carcinogenesis.
25:1543–1549. 2004.PubMed/NCBI
|
|
17
|
Andrecht S, Kolbus A, Hartenstein B, Angel
P and Schorpp-Kistner M: Cell cycle promoting activity of JunB
through cyclin A activation. J Biol Chem. 277:35961–35968. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmidt D, Textor B, Pein OT, et al:
Critical role for NF-κB-induced JunB in VEGF regulation and tumor
angiogenesis. EMBO J. 26:710–719. 2007.
|
|
19
|
Nausch N, Florin L, Hartenstein B, et al:
Cutting edge: the AP-1 subunit JunB determines NK cell-mediated
target cell killing by regulation of the NKG2D-ligand RAE-1ɛ. J
Immunol. 176:7–11. 2006.PubMed/NCBI
|
|
20
|
Hussaini IM, Trotter C, Zhao Y,
Abdel-Fattah R, et al: Matrix metalloproteinase-9 is differentially
expressed in nonfunctioning invasive and noninvasive pituitary
adenomas and increases invasion in human pituitary adenoma cell
line. Am J Pathol. 170:356–365. 2007. View Article : Google Scholar
|
|
21
|
Pulukuri SM and Rao JS: Matrix
metalloproteinase-1 promotes prostate tumor growth and metastasis.
Int J Oncol. 32:757–765. 2008.PubMed/NCBI
|
|
22
|
Xu D, McKee CM, Cao Y, et al: Matrix
metalloproteinase-9 regulates tumor cell invasion through cleavage
of protease nexin-1. Cancer Res. 70:6988–6998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawaguchi-Ihara N, Murohashi I, Nara N and
Tohda S: Promotion of the self-renewal capacity of human acute
leukemia cells by Wnt3A. Anticancer Res. 28:2701–2704.
2008.PubMed/NCBI
|
|
24
|
Hu J, Dong A, Fernandez-Ruiz V, et al:
Blockade of Wnt signaling inhibits angiogenesis and tumor growth in
hepatocellular carcinoma. Cancer Res. 69:6951–6959. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim D, Rath O, Kolch W and Cho KH: A
hidden oncogenic positive feedback loop caused by crosstalk between
Wnt and ERK pathways. Oncogene. 26:4571–4579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeong AY, Lee MY, Lee SH, Park JH and Han
HJ: PPARδ agonist-mediated ROS stimulates mouse embryonic stem cell
proliferation through cooperation of p38 MAPK and Wnt/β-catenin.
Cell Cycle. 8:611–619. 2009.
|
|
27
|
Gazitt Y, Kolaparthi V, Moncada K, Thomas
C and Freeman J: Targeted therapy of human osteosarcoma with 17AAG
or rapamycin: Characterization of induced apoptosis and inhibition
of mTOR and Akt/MAPK/Wnt pathways. Int J Oncol. 34:551–561.
2009.PubMed/NCBI
|
|
28
|
Samara KD, Antoniou KM, Karagiannis K, et
al: Expression profiles of Toll-like receptors in non-small cell
lung cancer and idiopathic pulmonary fibrosis. Int J Oncol.
40:1397–1404. 2012.PubMed/NCBI
|
|
29
|
Tanaka J, Sugimoto K, Shiraki K, et al:
Functional cell surface expression of toll-like receptor 9 promotes
cell proliferation and survival in human hepatocellular carcinomas.
Int J Oncol. 37:805–814. 2010.PubMed/NCBI
|
|
30
|
Takala H, Kauppila JH, Soini Y, et al:
Toll-like receptor 9 is a novel biomarker for esophageal squamous
cell dysplasia and squamous cell carcinoma progression. J Innate
Immun. 3:631–638. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiu J, Shao S, Yang G, Shen Z and Zhang Y:
Association of Toll like receptor 9 expression with lymph node
metastasis in human breast cancer. Neoplasma. 58:251–255. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lotze MT, Zeh HJ, Rubartelli A, et al: The
grateful dead: damage-associated molecular pattern molecules and
reduction/oxidation regulate immunity. Immunol Rev. 220:60–81.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sato Y, Goto Y, Narita N and Hoon DS:
Cancer cells expressing Toll-like receptors and the tumor
microenvironment. Cancer Microenviron. 2(Suppl 1): 205–214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ikebe M, Kitaura Y, Nakamura M, et al:
Lipopolysaccharide (LPS) increases the invasive ability of
pancreatic cancer cells through the TLR4/MyD88 signaling pathway. J
Surg Oncol. 100:725–731. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Agha-Mohammadi S and Lotze MT:
Immunomodulation of cancer: potential use of selectively
replicating agents. J Clin Invest. 105:1173–1176. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsai JP, Chen HW, Cheng ML, et al:
Analysis of host versus tumor interaction in cancer patients:
opposing role of transforming growth factor-β1 and interleukin-6 in
the development of in situ tumor immunity. Immunobiology.
210:661–671. 2005.PubMed/NCBI
|
|
37
|
Barbieri G, Rimini E and Costa MA: Effects
of human leukocyte antigen (HLA)-DR engagement on melanoma cells.
Int J Oncol. 38:1589–1595. 2011.PubMed/NCBI
|
|
38
|
König R, Stertz S, Zhou Y, et al: Human
host factors required for influenza virus replication. Nature.
463:813–817. 2010.PubMed/NCBI
|
|
39
|
Chen MH, Lin KJ, Yang WL, et al: Gene
expression-based chemical genomics identifies heat-shock protein 90
inhibitors as potential therapeutic drugs in cholangiocarcinoma.
Cancer. 119:293–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wei G, Twomey D, Lamb J, et al: Gene
expression-based chemical genomics identifies rapamycin as a
modulator of MCL1 and glucocorticoid resistance. Cancer Cell.
10:331–342. 2006. View Article : Google Scholar : PubMed/NCBI
|
